Schonfeld Strategic Advisors LLC 13D/13G Filings for Skye Bioscience, Inc. (SKYE)

Schonfeld Strategic Advisors LLC 13D and 13G filings for Skye Bioscience, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-05-15
4:31 pm
Purchase
2025-03-31 13G Skye Bioscience, Inc.
SKYE
Schonfeld Strategic Advisors LLC 1,617,697
5.220%
1,617,697increase
(New Position)
Filing